Eagle Claw Capital Managment, LLC Novartis Ag Transaction History

Eagle Claw Capital Managment, LLC

$573 Million
Q3 2024

A detailed history of Eagle Claw Capital Managment, LLC transactions in Novartis Ag stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 22,434 shares of NVS stock, worth $2.21 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

22,434

Previous 24,284 7.62%

Holding current value

$2.21 Million

Previous $2.59 Million 0.19%

% of portfolio

0.45%

Previous 0.48%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$106.13 - $120.89 $196,340 - $223,646	-1,850 Reduced 7.62%	22,434 $2.58 Million
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $62,878 - $71,590	660 Added 2.79%	24,284 $2.35 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $27,681 - $30,462	300 Added 1.29%	23,624 $2.39 Million
Q3 2023 Nov 07, 2023	BUY	$94.73 - $105.13 $71,047 - $78,847	750 Added 3.32%	23,324 $2.38 Million
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $69,390 - $78,682	-750 Reduced 3.22%	22,574 $2.28 Million
Q1 2023 May 04, 2023	SELL	$80.03 - $92.81 $79,549 - $92,253	-994 Reduced 4.09%	23,324 $2.15 Million
Q4 2022 Feb 09, 2023	BUY	$75.55 - $92.52 $38,379 - $47,000	508 Added 2.13%	24,318 $2.21 Million
Q4 2022 Feb 06, 2023	SELL	$75.55 - $92.52 $53,489 - $65,504	-708 Reduced 2.89%	23,810 $2.16 Million
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $27,978 - $32,722	-375 Reduced 1.51%	24,518 $1.86 Million
Q2 2022 Aug 08, 2022	BUY	$80.52 - $93.75 $6,683 - $7,781	83 Added 0.33%	24,893 $2.1 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $12,016 - $13,593	-150 Reduced 0.6%	24,810 $2.18 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $31,880 - $35,252	400 Added 1.63%	24,960 $2.18 Million
Q3 2021 Nov 05, 2021	BUY	$81.78 - $95.14 $53,157 - $61,841	650 Added 2.72%	24,560 $2.01 Million
Q2 2021 Aug 10, 2021	BUY	$85.24 - $94.15 $164,087 - $181,238	1,925 Added 8.76%	23,910 $2.18 Million
Q3 2020 Nov 09, 2020	BUY	$82.14 - $91.0 $71,872 - $79,625	875 Added 4.14%	21,985 $1.91 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $76,883 - $86,545	-950 Reduced 4.31%	21,110 $1.84 Million
Q1 2020 May 08, 2020	SELL	$70.67 - $99.01 $3,886 - $5,445	-55 Reduced 0.25%	22,060 $1.82 Million
Q3 2019 Oct 22, 2019	BUY	$85.54 - $94.26 $34,216 - $37,704	400 Added 1.84%	22,115 $1.92 Million
Q1 2019 May 01, 2019	BUY	$75.32 - $86.15 $37,660 - $43,075	500 Added 2.36%	21,715 $2.09 Million
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $26,776 - $30,972	400 Added 1.92%	21,215 $1.83 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $14,215 - $16,065	219 Added 1.06%	20,815 $1.57 Million
Q1 2018 May 18, 2018	BUY	$70.39 - $84.15 $49,273 - $58,905	700 Added 3.52%	20,596 $1.66 Million
Q4 2017 Feb 13, 2018	BUY	$72.33 - $77.64 $162,742 - $174,690	2,250 Added 12.75%	19,896 $1.67 Million
Q3 2017 Nov 16, 2017	SELL	$74.14 - $77.27 $44,484 - $46,362	-600 Reduced 3.29%	17,646 $1.52 Million
Q2 2017 Aug 15, 2017	BUY	N/A	18,246	18,246 $1.53 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Claw Capital Managment, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Claw Capital Managment, LLC with notifications on news.

Account

Eagle Claw Capital Managment, LLC Novartis Ag Transaction History